2009年度

●Solubilities of salicylic acid in pure solvents and binary mixtures containing cosolvent.

Hiroyuki Matsuda, Kenta Kaburagi, Sho Masumoto, Kiyofumi Kurihara, Katsumi Tochigi, Kazuo Tomono
J. Chem. Eng. Data, 54 (2), 480-484, 2009

●Construction of a model cell line for the assay of MDR1 (multi drug resistance gene-1) substrates/inhibitors using HeLa cells

Fumihiko Kugawa, Toyofumi Suzuki, Mariko Miyata, Kazuo Tomono, Fuyuhiko Tamanoi
Pharmazie, 64 (5), 296-300, 2009

●Nanoparticle processing in the solid state dramatically increases the cell membrane permeation of a cholesterol-lowering drug, probucol.

Toshiro Fukami, Tatsuya Ishii, Takeshi Io, Naoto Suzuki, Toyofumi Suzuki, Kazutoshi Yamamoto, Jiadi Xu, Ayyalusamy Ramamoorthy, Kazuo Tomono
Mol. Pharmceutics, 6 (3), 1029-1035, 2009

●Effectiveness of mechanochemical treatment with cyclodextrins on increasing solubility of glimepiride.

Mariko Iwata, Toshiro Fukami, Daiki Kawashima, Michiyo Sakai, Takayuki Furuishi, Toyofumi Suzuki, Kazuo Tomono, Haruhisa Ueda
Pharmazie, 64 (6), 390-394, 2009

●Characterization of multicomponent crystal formed between indomethacin and lidocaine.

Yukiko Umeda, Toshiro Fukami, Takayuki Furuishi, Toyofumi Suzuki, Katsuhisa Tanjoh, Kazuo Tomono
Drug Dev. Ind. Pharm., 35 (7), 843-851, 2009

●インドメタシンとリドカイン複合体の経皮吸収の検討

梅田 由紀子, 古石 誉之, 深水 啓朗, 鈴木 豊史, 鏑木 盛雄, 丹上 勝久, 伴野 和夫
薬剤学, 69(5), 384-391, 2009

●Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.

Takashi Masuko, Rie Namiki, Yuta Nemoto, Muneharu Miyake, Yasuo Kizawa, Toyofumi Suzuki, Keiko Kashiwagi, Kazuei Igarashi, Tadashi Kusama
J. Pharmcol. Exp. Ther., 331 (2), 522-530, 2009